Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XCEL-UMC-BETA in Chronic Traumatic Spinal Cord Injury
NCT03003364Phase 2Completed
- Sponsor
- Banc de Sang i Teixits
- Start
- Dec 2016
- Primary completion
- Jul 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in spinal cord injury (SCI), sponsored by Banc de Sang i Teixits. Started Dec 2016; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT03003364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03003364.